CAP TODAY/Illumina Webinar: In-house Hereditary Cancer Testing: Impacting Patient Treatment and Family Care Decisions

Description

In-house Hereditary Cancer Testing: Impacting Patient Treatment and Family Care Decisions

Why should you register now for this webinar?
Hear experts discuss the evolution of guideline-based testing for hereditary
prostate cancer from a historical to present clinical perspective. They will discuss how the guidelines and coverage have changed, and the impact on clinical care.
Moderated by: Emily Dalton, MS, CGC, Illumina Medical Affairs,
and Bob McGonnagle, Publisher, CAP TODAY
Presenters: Kathleen Latino, MD, and Ann E. Anderson, MD

What will this webinar empower you to do?

• Understand alternative service delivery models and innovative approaches to hereditary cancer testing to ensure appropriate test utilization for this patient population.
• Learn about Solaris Health, a leading national healthcare platform committed to enhancing access to specialty healthcare and continually improving patient outcomes.
• Identify strategies for integrating test data into the electronic health record and utilizing this data to stay at the cutting edge of patient care.
• Ask questions of our distinguished presenters